Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoelectrospray‐tandem mass spectrometry

Background: A defective mucus composition represents a key pathogenetic factor for intestinal injury. Phosphatidylcholine (PC) is an essential component contributing to formation of a hydrophobic mucus layer. For evaluation of PC in the pathogenesis of inflammatory bowel disease, the concentration and composition of PC in the rectal mucus of patients with ulcerative colitis was determined. Electrospray ionization (ESI) tandem mass spectrometry (MS/MS) allows quantification of PC species and enables analysis of crude extracts. Methods: Lipid extracts of material obtained by light scrapings of the intestinal lumen were analysed quantitatively by nanoESI MS/MS with synthetic internal PC and lysophosphatidylcholine (LPC) standards. PC and LPC species from rectoscopically acquired mucus aliquots of patients with ulcerative colitis were compared to Crohn disease and control subjects. Results: Patients with inactive ulcerative colitis showed significantly less PC and LPC (median 346 [IQR: 230–405] pmol total PC/mg dry weight) in rectal mucus compared to Crohn disease (median 1126 [IQR: 465–1941] pmol total PC/mg dry weight) and control subjects (median 1285 [IQR: 850–1639] pmol total PC/mg dry weight) (P < 0.05). The molecular species of PC and LPC were not significantly different between the groups. The most abundant species were PC 16:0/18:1; PC 16:0/18:2; PC 18:0/18:1; PC 18:0/18:2; LPC 16:0; and LPC 18:0. Conclusion: NanoESI MS/MS is a suitable tool for analysing and quantifying small amounts of PC in human mucus. Patients with ulcerative colitis have significant less PC in their intestinal mucus despite a comparable PC molecular species composition pattern. This suggests that a low amount of protective mucus PC is a characteristic feature in ulcerative colitis and explains an increased susceptibility to luminal contents.

[1]  R. Schutte,et al.  Potato Glycoalkaloids Adversely Affect Intestinal Permeability and Aggravate Inflammatory Bowel Disease , 2002, Inflammatory bowel diseases.

[2]  J. Schölmerich,et al.  Different Subsets of Enteric Bacteria Induce and Perpetuate Experimental Colitis in Rats and Mice , 2001, Infection and Immunity.

[3]  J. Madura.  Primary Bile Reflux Gastritis: Which Treatment is Better, Roux-en-Y or Biliary Diversion? , 2000, The American surgeon.

[4]  A. Mccutcheon.  Neurological damage and duodenopancreatic reflux in the pathogenesis of alcoholic pancreatitis. , 2000, Archives of surgery.

[5]  C. Fiocchi.  Inflammatory bowel disease: etiology and pathogenesis. , 1998, Gastroenterology.

[6]  J. Fox,et al.  Spontaneous Inflammatory Bowel Disease in Multiple Mutant Mouse Lines: Association with Colonization by Helicobacter hepaticus , 1998, Helicobacter.

[7]  W. Lehmann,et al.  Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  W. Lehmann,et al.  Characterization and quantification of rat bile phosphatidylcholine by electrospray-tandem mass spectrometry. , 1997, Analytical biochemistry.

[9]  J. Wallace,et al.  The cellular and molecular basis of gastric mucosal defense , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  F. Guarner,et al.  Polyunsaturated phosphatidylcholine prevents stricture formation in a rat model of colitis. , 1996, Gastroenterology.

[11]  B. Jeppsson,et al.  Gastrointestinal surface protection and mucosa reconditioning. , 1995, JPEN. Journal of parenteral and enteral nutrition.

[12]  W. Bernhard,et al.  Composition of phospholipid classes and phosphatidylcholine molecular species of gastric mucosa and mucus. , 1995, Biochimica et biophysica acta.

[13]  Xianlin Han,et al.  Electrospray ionization mass spectroscopic analysis of human erythrocyte plasma membrane phospholipids. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Graham,et al.  Phospholipase activity of Helicobacter pylori and its inhibition by bismuth salts. Biochemical and biophysical studies. , 1993, Digestive diseases and sciences.

[15]  R. Shamburek,et al.  Selective composition of biliary phosphatidylcholines is affected by secretion rate but not by bile acid hydrophobicity. , 1993, Journal of lipid research.

[16]  A. Allen,et al.  Gastroduodenal mucosal protection. , 1993, Physiological reviews.

[17]  P. Malfertheiner,et al.  Identification and characterization of Helicobacter pylori phospholipase C activity. , 1993, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

[18]  D. E. Wilson.  Role of Prostaglandins in Gastroduodenal Mucosal Protection , 1991, Journal of clinical gastroenterology.

[19]  J. Stachura,et al.  Gastric microvascular endothelium: a major target for aspirin‐induced injury and arachidonic acid protection. An ultrastructural analysis in the rat , 1990, European journal of clinical investigation.

[20]  A. Cantafora,et al.  Separation and determination of molecular species of phosphatidylcholine in biological samples by high-performance liquid chromatography. , 1990, Journal of chromatography.

[21]  L. Lichtenberger,et al.  A method to preserve extracellular surfactant-like phospholipids on the luminal surface of rodent gastric mucosa. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[22]  R. Eliakim,et al.  Intestinal surfactant-like material. A novel secretory product of the rat enterocyte. , 1989, The Journal of clinical investigation.

[23]  B. Hills,et al.  Surfactant approach to the gastric mucosal barrier: protection of rats by banana even when acidified. , 1989, Gastroenterology.

[24]  C. Benoni,et al.  Smoking habits in patients with inflammatory bowel disease. A case-control study. , 1987, Scandinavian journal of gastroenterology.

[25]  W. Shaw.  Possible role of lysolecithins and nonesterified fatty acids in the pathogenesis of Reye's syndrome, sudden infant death syndrome, acute pancreatitis, and diabetic ketoacidosis. , 1985, Clinical chemistry.

[26]  B. Butler,et al.  Distribution of surfactants in the canine gastrointestinal tract and their ability to lubricate. , 1983, The American journal of physiology.

[27]  S. Frost,et al.  Studies on fat digestion, absorption, and transport in the suckling rat. III. Composition of bile and evidence for enterohepatic circulation of bile salts. , 1982, Journal of lipid research.

[28]  Kawamoto Toshihiko,et al.  Biosynthesis and turnover of individual molecular species of phosphatidylcholine in liver and bile , 1980 .

[29]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[30]  G. Thomas,et al.  Inflammatory Bowel Disease and Smoking—A Review , 1998, American Journal of Gastroenterology.

[31]  L. Lichtenberger.  The hydrophobic barrier properties of gastrointestinal mucus. , 1995, Annual review of physiology.

[32]  R. Willén,et al.  Effects of phosphatidylcholine and phosphatidylinositol on acetic-acid-induced colitis in the rat. , 1992, Digestion.

[33]  G. Okano,et al.  Biosynthesis and turnover of individual molecular species of phosphatidylcholine in liver and bile. , 1980, Biochimica et biophysica acta.